University of Dundee

CLS Impact and Outreach

Life Sciences staff make Converge 2021 Semi-finals

Dr Helge Dorfmueller and Dr David Martin from the School have been announced as semi-finalists of Converge 2021.

Dr Dorfmueller has created RhaPSeda, a platform that could prove decisive in the battle against the a contagious bacteria StrepA that kills 500,000 people annually, mainly from low-income countries. Despite a 100-year hunt for a vaccine, none currently exists with the pathogen showing increasing signs of antibiotic resistance. RhapSeda’s patented technology significantly reduces manufacturing costs, taking us a step closer to a worldwide solution to this global killer.

Commendations for SLS at Stephen Fry Public Engagement Awards

As part of the University of Dundee’s Celebrating our Public Engagement event, the University crowned the latest winners of the Stephen Fry Awards for Excellence in Public Engagement.

The awards celebrate the people and projects that engage with wider audiences, and the benefits they bring to society. The winners across the three categories were announced by former Rector Stephen Fry:

£38 million investment in University spinout

Amphista Therapeutics, a University of Dundee spinout company, has announced a near-£40 million investment that will further its work to develop new drugs for a range of diseases.

Amphista is a biopharmaceutical company creating first-in-class therapeutics that harness the body’s natural processes to selectively and efficiently degrade and remove disease-causing proteins. The company is a spinout from Professor Alessio Ciulli’s labs at the University’s School of Life Sciences.

Entrepreneur can “provide a glimpse” of Dundee’s future

A University of Dundee masterclass could help to inspire the city’s next generation of bio-entrepreneurs. Dr Deborah O’Neil, founder and CEO of leading clinical-stage biotechnology company Novabiotics, will be sharing her experiences in the world of business as host of the University’s latest Entrepreneurial Masterclass.

With more than two decades of experience in anti-infective drug discovery research and development, she will share the secrets of her success at "Actually Doing It - The Start of Your Journey as a Bio-Entrepreneur,” on Wednesday 17 March.

Women in STEM take over Science Centre

A host of fun activities aimed at promoting STEM subjects to girls and young women launches in Dundee today.

As part of Dundee Women’s Festival (Friday 5 to Sunday 14 March 2021) and International Women’s Day (Monday 8 March 2021), Dundee Science Centre is teaming up with women scientists at the University of Dundee to promote STEM subjects to younger children.

Dundee honoured for commitment to public engagement

The University of Dundee has become the first university in Scotland – and only the third in the UK – to receive a Gold Watermark in recognition of its commitment to public engagement.

The National Co-ordinating Centre for Public Engagement (NCCPE) runs the Engage Watermark – a charter mark awarded to universities for excellence in their support and practice of public engagement in all aspects of their work. Dundee was awarded the highest level of accolade currently available following a rigorous assessment involving staff from across the University and partner organisations.

Seed investment for School spin-out In4Derm

The o2h human health EIS Fund has announced its intention to lead an investment into In4Derm, an innovative drug discovery company that is developing next generation topical and oral therapies for widespread inflammatory conditions such as eczema and rheumatoid arthritis. Syndicating with o2h ventures are Meltwind and Wren to complete a first investment in In4Derm.

A spin out from the School, the team has been recognised as Scotland’s top spin out opportunity for 2020 having won the top prize in the 2019 Converge Challenge competition.  

Pages